Status:
UNKNOWN
Slimming Myokines, Cancers,Nutritional and Psychology Support
Lead Sponsor:
Ordu University
Conditions:
Cancer
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
With the project investigators propose, investigators aim to find answers to the following questions: The fact that irisin and atropine are slimming the proteins that cause an increase in weight loss,...
Detailed Description
Cancer is the excessive and uncontrolled proliferation of a group of cells in the body. Problems experienced in cancers (cachectic cancers) which are known to be more underweight than other types of c...
Eligibility Criteria
Inclusion
- Must be older than 18 years of age, Clinical diagnosis of pancreatic, colon, renal, bladder cancer, and not having any other chronic disease.
Exclusion
- major gastrointestinal disease, chronic renal failure, uncontrolled diabetes, and HIV
- body mass index\>30kg/m2,
- patients receiving drug therapy that modulates metabolism or weight deeply,
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05278078
Start Date
August 1 2022
End Date
August 1 2024
Last Update
March 14 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.